l9n/ Oregon

2007 Regular Session

Senate Joint Memorial 8

Urges Congress to enact legislation requiring testing, review and approval of ingredients in cosmetics, personal care products and children's toys prior to marketing or sale and requiring manufacturers of cosmetics and personal care products to label all ingredients.

Filed with the Secretary of State, on June 14, 2007.

What it does

The synopsis the Legislative Assembly published with the bill.

Urges Congress to enact legislation requiring testing, review and approval of ingredients in cosmetics, <i>particularly dibutyl phthalate and diethyl phthalate</i>] <b>personal care products and children's toys prior to marketing or sale and requiring manufacturers of cosmetics and personal care products to label all ingredients</b>.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the Senate

1 co-sponsor

Laurie Monnes Anderson

In the House of Representatives

    5 co-sponsors

    Sara Gelser Blouin, Nancy Nathanson, Mary Nolan, Diane Rosenbaum, Carolyn Tomei

    Votes

    Yeas to nays, as the Legislative Assembly recorded them. Committee votes are set in.

    • Senate, adoption29–0

      Passed · May 9 · 1 present

    • House of Representatives, adoption41–0

      Passed · Jun 6 · 19 present

    Amendments

    Each amendment offered, and what became of it.

    • Senate committee amendmentAdopted

      Adopted May 7

    Text

    Each version as the Legislative Assembly printed it.

    l9n doesn't hold this bill's text yet.

    What happened

    In l9n's words, one line for each step. Every action as the Legislative Assembly published it is below.

    In the Senate Mar 5 – May 9

    1. Mar 5Introduced
    2. Mar 12Sent to Health Policy and Public Affairs
    3. Apr 18Heard in Health Policy and Public Affairs
    4. Apr 30Heard in Health Policy and Public Affairs
    5. May 7Health Policy and Public Affairs recommended it as amended
    6. May 8Read a second time
    7. May 9Adopted in the Senate, 29 to 0

    In the House of Representatives May 10 – Jun 6

    1. May 10Arrived in the House of Representatives
    2. May 11Sent to Human Services and Women's Wellness
    3. May 23Heard in Human Services and Women's Wellness
    4. May 24Human Services and Women's Wellness recommended it
    5. Jun 6Adopted in the House of Representatives, 41 to 0

    In the Senate Jun 12

    1. Jun 12Signed in the Senate

    In the House of Representatives Jun 14

    1. Jun 14Signed in the House of Representatives

    In the Senate Jun 14

    1. Jun 14Filed with the Secretary of State
    All 17 actions, as published
    1. Mar 5Introduction and first reading. Referred to President's desk.Senate
    2. Mar 12Referred to Health Policy and Public Affairs.Senate
    3. Apr 18Public Hearing held.Senate
    4. Apr 30Public Hearing and Work Session held.Senate
    5. May 7Recommendation: Do adopt with amendments. (Printed A-Eng.)Senate
    6. May 8Second reading.Senate
    7. May 9Final reading. Carried by Carter. Adopted.Senate
    8. May 9Westlund, excused, granted unanimous consent to vote aye.Senate
    9. May 10First reading. Referred to Speaker's desk.House of Representatives
    10. May 11Referred to Human Services and Women's Wellness.House of Representatives
    11. May 23Public Hearing and Work Session held.House of Representatives
    12. May 24Recommendation: Be adopted.House of Representatives
    13. May 25Rules suspended. Made a Special Order of Business on June 6, 2007 Calendar.House of Representatives
    14. Jun 6Read. Carried by Maurer. Adopted.House of Representatives
    15. Jun 12President signed.Senate
    16. Jun 14Speaker signed.House of Representatives
    17. Jun 14Filed With Secretary of State.Senate